Thursday, 24 January 2013

Cerebral Aneurysms Global Clinical Trials Review, H1, 2013

Summary
GlobalData’s clinical trial report, Cerebral Aneurysms Global Clinical Trials Review, H1, 2013″ provides data on the Cerebral Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Aneurysms. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cerebral Aneurysms. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 
Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Cerebral Aneurysms 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by BRIC Nations 12
Clinical Trials by G7 Nations 13
Clinical Trials in G7 Nations by Trial Status 14
Clinical Trials by E7 Nations 15
Clinical Trials in E7 Nations by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Prominent Drug Comparison 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Universities / Institutes / Hospitals 24
Graduate School of Medicine and Faculty of Medicine Kyoto University 24
Clinical Trial Overview of Graduate School of Medicine and Faculty of Medicine Kyoto University 24
Seoul National University Bundang Hospital 25
Clinical Trial Overview of Seoul National University Bundang Hospital 25
Second Military Medical University 26
Clinical Trial Overview of Second Military Medical University 26
Utrecht University 27
Clinical Trial Overview of Utrecht University 27
Shanghai Jiao Tong University 28
Clinical Trial Overview of Shanghai Jiao Tong University 28
University of Virginia 29
Clinical Trial Overview of University of Virginia 29
Medical University of South Carolina 30
Clinical Trial Overview of Medical University of South Carolina 30
Samsung Medical Center 31
Clinical Trial Overview of Samsung Medical Center 31
University Hospital Freiburg 32
Clinical Trial Overview of University Hospital Freiburg 32
Kyoto University 33
Clinical Trial Overview of Kyoto University 33
Kuopio University Hospital 34
Clinical Trial Overview of Kuopio University Hospital 34
Vanderbilt University 35
Clinical Trial Overview of Vanderbilt University 35
Monash University 36
Clinical Trial Overview of Monash University 36
Johann Wolfgang Goethe University Hospitals 37
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 37
Washington University School of Medicine 38
Clinical Trial Overview of Washington University School of Medicine 38
University of California, San Francisco 39
Clinical Trial Overview of University of California, San Francisco 39
Five Key Clinical Profiles 40

Appendix 54
Abbreviations 54
Definitions 54
Research Methodology 55
Secondary Research 55
About GlobalData 56
Contact Us 56
Disclaimer 56
Source 57

Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Zone, 2013* 6
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 9
Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Countries, 2013* 10
Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries, 2013* 11
Cerebral Aneurysms Therapeutics Clinical Trials, BRIC Countries, 2013* 12
Cerebral Aneurysms Therapeutics Clinical Trials, G7 Countries, 2013* 13
Cerebral Aneurysms Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 14
Cerebral Aneurysms Therapeutics Clinical Trials, E7 Countries, 2013* 15
Cerebral Aneurysms Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 16
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Phase, 2013* 17
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 18
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 19
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 20
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 22
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 23
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Graduate School of Medicine and Faculty of Medicine Kyoto University, 2013* 24
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Bundang Hospital, 2013* 25
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Second Military Medical University, 2013* 26
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Utrecht University, 2013* 27
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University, 2013* 28
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2013* 29
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2013* 30
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2013* 31
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2013* 32
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2013* 33
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2013* 34
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 35
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Monash University, 2013* 36
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2013* 37
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2013* 38
Cerebral Aneurysms Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 39
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 6
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Cerebral Aneurysms Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 9
Cerebral Aneurysms Therapeutics Clinical Trials, Europe, Top Countries (%), 2013* 10
Cerebral Aneurysms Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 11
Cerebral Aneurysms Therapeutics Clinical Trials, G7 Countries (%), 2013* 13
Cerebral Aneurysms Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 14
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 17
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 18
Cerebral Aneurysms Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 19
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 20
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 21
Cerebral Aneurysms Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 23
GlobalData Methodology 55

Visit: http://www.marketresearchreports.biz/analysis/158941


Cerebral Aneurysms Global Clinical Trials Review, H1, 2013

No comments:

Post a Comment